HKU Technology Transfer Office (HKUTTO)

What HKU Technology Transfer Office (HKUTTO) does

HKU Technology Transfer Office (HKUTTO) operates as the technology transfer unit within HKU RISE (Research, Innovation, Strategic Partnerships, and Entrepreneurship), the innovation and technology transfer arm of The University of Hong Kong. The TTO's function is to commercialize HKU research through IP protection, licensing, sponsored research, consultancy, and spin-off formation. Its core commercial channel is HKU Versitech Limited, a wholly-owned subsidiary that negotiates and manages commercial contracts on behalf of the university, with a dedicated business development team spanning science & engineering and biotechnology verticals. The TTO serves four primary customer segments: industry partners and corporations seeking licensed technologies, investors and venture capital, HKU researchers and start-ups, and government/research institutions (including InnoHK clusters).

The TTO's underlying asset base consists of 500+ active patents and patent applications (2024-25) and six flagship technology offerings spanning AI/operations research (OptiMax AI Supply Chain Management Platform), assistive robotics (Exynergy wearable robots with Shear Thickening Gel artificial muscles), medical imaging (intraoperative infrared fluorescence imaging in the 1000-1700 nm range), OLED materials (proprietary molecular emitters reducing reliance on iridium phosphors), immunotherapy (Δ42PD1 antibody drug platform via Orimmune spin-off), and luminescent materials (Gold(III) compounds for portable healthcare devices). Revenue mechanics combine licensing royalties, sponsored research, consultancy fees, and equity stakes in spin-off companies. Notable transactions include the HK$300M Gobi-HKU Fund I (March 2026) with Gobi Partners and HKIC, and HK$220M+ in RAISe+ funding and industry matching for the Orimmune Δ42PD1 program. The TTO operates from HKU's Pokfulam campus with extended reach via HKUSIRI (Shenzhen), ZIRI (Hangzhou), and the Suzhou Innovation Corridor.

The TTO is positioned within Hong Kong's broader innovation ecosystem, hosting 33.3% of Hong Kong's State Key Laboratories and benefiting from government-backed vehicles (RAISe+ grants, InnoHK clusters, HKIC capital). HKU ranks #13 globally in Clarivate's highly cited researchers count. Strategic partnerships in 2025 with China Mobile, China Merchants Group, GETECH, TCL, and Shanghai Innovation Institute have established joint labs and centers spanning industrial AI, biopharmaceuticals, and energy/sustainability AI. The TTO is part of a public university structure and does not have a separate incorporation; HKU RISE itself is the umbrella entity, with HKU Versitech and HKU Innovation Holding Ltd as wholly-owned commercial subsidiaries. The TTO lists 9 employees directly, though the broader RISE ecosystem is much larger.

Name

HKU Technology Transfer Office (HKUTTO)

Legal name

HKU RISE, The University of Hong Kong

Website

https://tto.hku.hk

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

HKUTTO is the technology transfer office of The University of Hong Kong, operating within HKU RISE to commercialize university research through IP licensing, sponsored research, and spin-off creation. It serves industry partners, investors, and HKU researchers, with HKU Versitech acting as its commercial arm.

Ownership category

akta.pro rank

Product category

University Technology Transfer Services

NAICS

Scientific Research and Development Services (5417), Professional, Scientific, and Technical Services (541)

SIC

Patent Owners & Lessors (6794)

akta.pro primary industry

IP Licensing, Transactions & Technology Transfer (BPAHAMAF)

akta.pro secondary industries

Patent Prosecution & Portfolio Management (BPAHAMAA), IP Search, Watch & Competitive Intelligence (BPAHAMAI), Technology Transfer & Innovation-Driven Research Universities (High Commercialization) (EDAHABAH)

Keywords

• Technology transfer services
• University research commercialization
• Patent licensing services
• Sponsored research programs
• Spin-off incubation

Headquarters

HQ city

Hong Kong

HQ country

China

HQ region

Asia

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Technology Licensing: Revenue generated from licensing HKU-developed technologies to industry partners, including patents and know-how licensing agreements.
2. Knowledge Transfer Income: Total income generated from knowledge transfer activities including licensing, consultancy services, and other commercialization activities (HK$ billions, 2024-25).
3. Sponsored Research: Industry partners sponsor or collaborate on specific research projects, providing research funding while securing first right to negotiate licenses for resulting IP.
4. Start-up Equity: Commercialization through creation of spin-off companies, with HKU holding equity stakes in start-ups emerging from university research.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

HKUTTO commercializes research output of The University of Hong Kong by managing intellectual property, negotiating patent and know-how licensing agreements, executing sponsored and collaborative research contracts, and supporting the creation of spin-off companies. Its portfolio includes licensable research technologies in AI/supply chain optimization, wearable robotics, surgical imaging, OLED materials, antibody therapeutics, and luminescent healthcare materials.

Product overview

HKU RISE serves as the University of Hong Kong's technology transfer and innovation hub, offering a portfolio of research-based technology offerings across multiple domains. The portfolio includes six distinct technology platforms: the Data-driven AI Supply Chain Management Platform for industrial optimization; Wearable Robots for assisting older adults; Intraoperative Infrared Fluorescence Imaging for surgical guidance; Innovative Molecular Emitters for OLED and wearable device applications; the Δ42PD1 Antibody Drug immunotherapy platform; and Gold (III) Luminescent Materials for healthcare devices. These technologies represent HKU's commercialization pipeline, managed through HKU Versitech for industry partnerships and technology licensing.

Differentiator

Problem solved

Functional benefit

Products and services

• Data-driven AI Supply Chain Management Platform (OptiMax)

Quantifiable outcome

• HK$3 billion+ total knowledge transfer income (2024-25)
• +4 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Six partnerships are on record, tiered major.

• Suzhou Kowloon HospitalmajorStrategic or Co-development Partner · 1 March 2026HKU and Suzhou Kowloon Hospital launched the HKU-Suzhou Innovation Corridor to deepen medical technology collaboration between Hong Kong and mainland China, fostering industry-academia-research-investment integration.
• Yangtze Delta Innovation CentermajorStrategic or Co-development Partner · 1 March 2026HKU signed cooperation MOU with Yangtze Delta National Technology Innovation Center to promote technology transfer and talent cultivation across the Yangtze Delta region.
• Shanghai Innovation Institute (SII)majorStrategic or Co-development Partner · 1 January 2025HKU and SII signed Memorandum of Understanding to jointly establish the Hong Kong-Shanghai AI Institute for Energy and Sustainability (AI4ES), focusing on AI applications for energy and sustainability sectors.
• China MobilemajorStrategic or Co-development Partner · 1 January 2025HKU and China Mobile established a Joint Innovation Centre to collaborate on technology innovation and research commercialization in telecommunications and digital services.
• China Merchants GroupmajorStrategic or Co-development Partner · 1 January 2025HKU signed agreement with China Merchants Group on peptide drug innovation and discovery to pioneer collaboration in biopharmaceutical research, leveraging HKU's life sciences expertise.
• GETECH and TCLmajorStrategic or Co-development Partner · 1 January 2025HKU signed agreement with GETECH and TCL to establish a Joint Lab for Industrial AI Innovation, combining industry expertise with HKU's research capabilities in AI applications.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Stanford Office of Technology Licensing (OTL): Stanford University's central technology transfer office, managing patent prosecution, licensing, and spin-off formation for one of the world's leading research universities. Direct functional peer in managing IP, licensing, and industry partnerships out of a top-tier research base.
• Cambridge Enterprise: University of Cambridge's technology transfer office, providing IP protection, licensing, and seed funding for spin-outs. Directly comparable in handling a deep life-sciences and physical-sciences IP portfolio from a top global research base.
• MIT Technology Licensing Office: MIT's TLO handles invention disclosure, patent prosecution, and licensing for MIT research. Most comparable peer in scale and breadth of biotech, materials, and AI IP commercialization from a top global research institution.
• Oxford University Innovation: University of Oxford's technology transfer and spin-out company, handling IP commercialization, consulting, and venture creation. Highly comparable in managing a multi-disciplinary life sciences, AI, and materials portfolio from a leading research university.
• ETH Zurich Technology Transfer Office: ETH Zurich's central office for IP management, licensing, and spin-off creation out of a world-leading STEM research institution. Comparable in handling physical-sciences, AI, and engineering IP at scale from a top global research base.
• Max Planck Innovation: Technology transfer arm of the Max Planck Society, managing IP and licensing for one of Europe's largest basic-research organizations. Comparable in managing a deep, multi-disciplinary research IP portfolio with focus on life sciences and physical sciences.
• Imperial College Innovations: Imperial College London's technology transfer arm, focused on deep-tech and life-sciences commercialization from a research-intensive institution. Comparable in scale and sector mix (biotech, medtech, AI, materials).
• Tsinghua Holdings (Tus-Holdings / TusTech): China's leading university-affiliated technology transfer and investment platform, originating from Tsinghua University. Most direct regional peer given Hong Kong-China cross-border innovation dynamics and overlapping mandates in deep-tech commercialization.

Regional players

• NTUitive (Nanyang Technological University): NTU Singapore's technology transfer and innovation enterprise unit, operating in the same regional ecosystem (Greater China + Southeast Asia) with overlapping deep-tech and biotech mandates. Regional peer with comparable scale and structure.
• University of Tokyo TLO (CASTI): Japan's pioneering university TLO, established in 1998, handling IP licensing and spin-offs from the University of Tokyo. Regional peer operating in the Asia-Pacific research-transfer ecosystem with comparable cross-border dynamics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/hkutechnologytransferoffice

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HKU Technology Transfer Office (HKUTTO)